HONG KONG, May 21, 2025 (GLOBE NEWSWIRE) -- UCLOUDLINK GROUP INC. (“UCLOUDLINK” or the “Company”) (NASDAQ: UCL), the world’s first and leading mobile data traffic sharing marketplace, today announced its unaudited financial results for the three months ended March 31, 2025. First Quarter 2025 Financial Highlights Total revenues were US$18.7 million, representing an increase of 3.4% from US$18.1 million in the first quarter of 2024.Gross profit was US$9.7 million, representing a decrease of 3.1% from US$10.0 ...

AVTL files Red Herring Prospectus Rotterdam, the Netherlands, 21 May 2025Today, we announce an update regarding the primary equity issue of our joint venture AVTL.AVTL has received approval from the Securities and Exchange Board of India (‘SEBI’) and has filed the Red Herring Prospectus with the Registrar of Companies Gujarat at Ahmedabad and thereafter submitted to SEBI and the stock exchanges. The price band for the primary equity issue was approved by the board of AVTL on 20 May 2025, which ranges betwee ...

Group 1 - The event "Hydro's Investor Day 2025" is scheduled for November 27, 2025, in London from 09:00 to 14:00 GMT, allowing for both in-person and virtual attendance [1] - Presentations will be conducted by Hydro's CEO and CFO, focusing on strategic priorities and financial targets, followed by Q&A and roundtable sessions [1] - Further details and a formal invitation with registration information will be provided at a later date [1]

Core Insights - Nokia is recognized as the sole Champion and Market Momentum Leader in Omdia's 2025 Private 5G Market Radar report, highlighting its strong product portfolio and investment in mission-critical connectivity solutions for various industrial sectors [2][3][5] - The report emphasizes Nokia's leadership in private wireless networks, having deployed 890 private 4G and 5G networks globally as of Q1 2025, showcasing its proactive engagement in the ecosystem to drive market adoption [3][4] Company Overview - Nokia's private wireless solutions extend beyond connectivity to include edge computing and AI platforms, supported by a rich ecosystem of applications and partners such as Kyndryl, Telefonica Tech, and Verizon [4][6] - The company's portfolio includes solutions like Nokia Digital Automation Cloud (DAC), Modular Private Wireless (MPW), and Core Enterprise Solutions, featuring patented innovations such as MX Industrial Edge and AI-powered solutions [7][8] Market Position - Omdia's report indicates that Nokia is the only vendor classified as a Champion, recognized for its ability to accelerate Industry 4.0 transformation through integrated platforms that cater to diverse industries [3][5] - Nokia's commitment to delivering robust and scalable networks is reflected in its ongoing development of solutions that meet the demanding needs of industrial environments [6][10]

Core Points - Belite Bio, Inc. has received Breakthrough Therapy Designation from the FDA for Tinlarebant, aimed at treating Stargardt disease (STGD1), which currently has no approved therapies [1][2] - The designation is based on interim data from the Phase 3 DRAGON trial, indicating substantial improvement over existing therapies and a favorable safety profile [2][6] - The DRAGON trial is a global study involving 104 subjects across 11 jurisdictions, designed to evaluate the safety and efficacy of Tinlarebant [5][6] Company Overview - Belite Bio is focused on developing novel therapeutics for degenerative retinal diseases, including STGD1 and Geographic Atrophy (GA) [8] - Tinlarebant is an orally administered tablet intended for early intervention in maintaining retinal health, with no current FDA-approved treatments for STGD1 or GA [7][8] - The company is also conducting a Phase 2/3 study (DRAGON II) and a Phase 3 study (PHOENIX) for other related conditions [8] Clinical Trial Insights - The Phase 3 DRAGON trial is randomized, double-masked, and placebo-controlled, with a primary efficacy endpoint focused on the growth rate of atrophic lesions [5] - The trial's completion is expected by Q4 2025, including a three-month follow-up period [6] - Tinlarebant has previously received multiple designations, including Fast Track and Rare Pediatric Disease Designations in the U.S. [6]

Fleet Utilization - Fleet utilization for April 2025 was reported at 58 percent [1] - Safe Zephyrus and Safe Eurus achieved 100 percent commercial uptime during April [1] - Safe Notos had a commercial uptime of 92 percent due to required repairs [1] Contract Updates - Safe Caledonia has been re-activated for a UK contract starting on June 1 [1] - Safe Boreas is in the process of being transported to Singapore for a contract in Australia [1] - Safe Scandinavia has been sold for recycling and has been delivered to the buyer [1] Company Overview - Prosafe is a leading owner and operator of semi-submersible accommodation vessels [2] - The company is listed on the Oslo Stock Exchange with the ticker code PRS [2]

Core Insights - IDEX Biometrics ASA announced a new strategy on 11 March 2025, indicating a fundamental shift in how the company will market its unique technology and products [1] - The company appointed a new CEO, Anders Storbråten, to lead this strategic change [1] - IDEX secured a new debt facility of NOK 30 million, which has been converted to shares, and renegotiated the Heights convertible bond [1] - Operational improvement initiatives are underway, targeting a quarterly run rate of operating expenses (OPEX) between $1.5 million and $1.7 million by the end of Q3 2025 [1] Financial Performance - In Q1 2025, IDEX Biometrics reported revenues of $0.1 million [2] - Ordinary operating expenses for the quarter amounted to $2.4 million [3] - The net loss for the quarter was $4.1 million [3] - As of 31 March 2025, the cash balance stood at $1.1 million [3] Business Developments - The company received a production order valued at approximately USD 50,000 from Beautiful Card Corporation in Japan [2] - An order was also received from DigAware for a biometric sensor solution for access cards [2] - IDEX Biometrics secured an order for 10,000 VISA biometric cards in the Middle East & Africa region [2] - KONA I received a Letter of Approval from Mastercard for IDEX Pay biometric cards [2] - The company completed a debt conversion and launched a subsequent offering for investors to participate under the same terms as shareholders [2]

Core Points - IDEX Biometrics ASA has successfully completed a loan financing of NOK 30 million, which has been converted into 3,000,000,000 new shares at a subscription price of NOK 0.01 per share [1] - The company is offering up to 600,000,000 new shares at the same subscription price as the debt conversion, pending approval of a prospectus by the Financial Supervisory Authority of Norway [1][2] - The subscription period for the subsequent offering is set to begin on 22 May 2025 and will end on 5 June 2025 at 16:30 CET [3] Company Information - IDEX Biometrics ASA is a global leader in fingerprint biometrics, providing authentication solutions for payments, access control, and digital identity [5] - The company focuses on card-based applications for payments and digital authentication, partnering with leading card manufacturers and technology companies [5]

Key information relating to the dividend to be paid by Golden Ocean Group Limited for the first quarter, 2025: Dividend amount: $0.05 per share Declared currency: USD. Dividends payable to shares registered with Euronext VPS will be distributed in NOK. Last day including right: June 3, 2025 Ex-date: June 4, 2025 Record date: June 5, 2025 Payment date: On or about June 17, 2025. Due to the implementation of CSDR in Norway, dividends payable on shares registered with Euronext VPS is expected to be distributed ...

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO ANY JURISDICTION IN WHICH DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL Reference is made to Svitzer Group A/S’ (Svitzer) company announcement dated 16 May 2025 regarding the final result and completion of APMH Invest A/S’ (APMHI) all-cash voluntary recommended purchase offer to acquire all of the issued shares (the Shares) in Svitzer, except for Shares owned by APMHI and Shares held by Svitzer and/or its subsidiaries in treasury, if any. Follo ...